Table 2.
Liver function parameters before and 1 month after the procedure
| Parameters | All (n=59) |
Brachytherapy group (n=34) |
Control group (n=25) |
P value |
|---|---|---|---|---|
| ALT (U/L) | ||||
| Before | 57.58±26.66 | 60.51±25.58 | 53.60±28.09 | 0.329 |
| After | 44.71±16.64 | 46.97±16.36 | 41.62±16.85 | 0.226 |
| P value | 0.002* | 0.004* | ||
| AST (U/L) | ||||
| Before | 68.87±33.10 | 65.57±30.74 | 73.35±36.22 | 0.377 |
| After | 46.66±19.84 | 45.59±21.22 | 48.10±18.13 | 0.635 |
| P value | 0.000* | 0.000* | ||
| TBIL (μmol/L) | ||||
| Before | 324.47±186.75 | 305.18±194.12 | 350.71±176.69 | 0.359 |
| After | 65.07±31.09 | 61.93±33.48 | 69.34±27.60 | 0.370 |
| P value | 0.000* | 0.000* | ||
| DBIL (μmol/L) | ||||
| Before | 260.93±142.22 | 247.43±152.21 | 279.29±128.12 | 0.400 |
| After | 54.19±27.41 | 51.02±29.38 | 58.50±24.40 | 0.304 |
| P value | 0.000* | 0.000* | ||
Liver function parameters including ALT, AST, TBIL, and DBIL decreased significantly from before to 1 month after the procedure, * p value ≤ 0.05 was considered to indicate statistical significance
ALT Alanine aminotransferase, AST Aspartate aminotransferase, TBIL Total bilirubin, DBIL direct bilirubin